Q2 2026 Precipio Inc Earnings Call Transcript
Key Points
- Precipio Inc (PRPO) achieved a record quarterly revenue of over $7 million, a 22% year-over-year increase.
- The company returned to positive adjusted EBITDA of approximately $400,000, a $600,000 improvement from Q1.
- Precipio Inc (PRPO) generated approximately $700,000 in operating cash flow, ending the quarter with over $3 million in cash, an increase of $0.5 million without raising capital.
- Product revenue reached a record $900,000, up 35% sequentially and 21% above the previous record, driven by a growing commercial pipeline.
- The commercial team added 10 new distributor reps and identified over 25 new qualified customers, positioning for further growth in the second half of 2026.
- Pathology division revenue growth was modest, increasing only slightly from $6.0 million to $6.1 million sequentially.
- The company acknowledged that quarter-to-quarter timing of product shipments can create variability, as seen in Q1's flat revenue.
- The CEO expressed uncertainty about the source of unusually high trading volume, indicating a lack of transparency into market activity.
- The company's reliance on large distributors like Thermo Fisher and McKesson requires complex relationship management, which has historically slowed the ramp-up of product sales.
- Despite progress, the product business is still in early stages of scaling, with pipeline conversion expected to contribute more significantly only in the second half of the year.
Welcome to the Precipio Q2 2026 shareholder update conference call. (Operator Instructions) Please note that the conference is being recorded. Statements made during this call contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements as these statements are based upon our current expectations, forecasts, and assumptions and are subject to significant risks and uncertainties.
These statements may be identified by words such as may, will, should, could, expect, intend, plan, anticipate, believe, estimate, predict, potential, forecast, continue or the negative of these terms or other words or terms of similar meaning.
Risks and uncertainties that could cause our actual results to differ materially from those set forth in any forward-looking statements include, but are not limited to, the matters listed under the Risk Factors in our annual report on Form 10-K for the year ended December 31, 2025, which is on file with the Securities and Exchange Commission as well as other risks detailed in our subsequent filings with the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
